Nuvectis Pharma Inc
NASDAQ:NVCT
Balance Sheet
Balance Sheet Decomposition
Nuvectis Pharma Inc
Nuvectis Pharma Inc
Balance Sheet
Nuvectis Pharma Inc
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
6
|
20
|
19
|
19
|
|
| Cash Equivalents |
0
|
6
|
20
|
19
|
19
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
6
|
20
|
19
|
19
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
7
N/A
|
20
+206%
|
19
-6%
|
19
-3%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
1
|
3
|
3
|
2
|
|
| Accrued Liabilities |
0
|
1
|
3
|
4
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
6
|
7
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
2
+24 100%
|
6
+156%
|
7
+13%
|
9
+27%
|
|
| Equity | ||||||
| Common Stock |
0
|
15
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
13
|
32
|
54
|
73
|
|
| Additional Paid In Capital |
0
|
2
|
46
|
66
|
83
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
4
N/A
|
14
+235%
|
12
-14%
|
10
-20%
|
|
| Total Liabilities & Equity |
0
N/A
|
7
N/A
|
20
+206%
|
19
-6%
|
19
-3%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
0
|
0
|
15
|
17
|
19
|
|